Clinical Trials Directory

Trials / Completed

CompletedNCT03326999

Does Adding an Additional Numbing Medication Injection in the Thigh Help With Pain Control After Knee Replacement Surgery?

Evaluating the Addition of Obturator Nerve Block to Adductor Canal Block for Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

One common anesthetic that is performed for total knee replacement surgery is spinal anesthesia with an adductor canal regional block, which involves injecting numbing medication in the thigh region for pain control after surgery. The aim of this study is to determine whether the addition of another regional block called obturator nerve block, which involves injecting numbing medication in the upper thigh region, will improve pain control after surgery while not sacrificing mobility after surgery.

Detailed description

There is currently no consensus on the optimal strategy that provides the most effective postoperative analgesia while preserving ambulation and limiting side effects such as nausea and vomiting. The clinical team's hypothesis is that the obturator nerve block in addition to adductor canal block can target both the anterior and posterior distribution of nerves to the knee to provide superior analgesia while not limiting ambulation. To test this hypothesis, the clinical team will compare the rate of IV opioid consumption in patients who receive a combination of adductor canal block and obturator nerve block at the surgical site versus patients who receive adductor canal block alone.

Conditions

Interventions

TypeNameDescription
DRUGObturator nerve regional blockObturator nerve regional block involves the injection of a local anesthetic called bupivacaine into the upper thigh.
DRUGAdductor canal regional blockAdductor canal regional block, which involves injecting numbing medication in the thigh region for pain control.
DRUGSalineSaline as placebo comparator

Timeline

Start date
2017-12-11
Primary completion
2018-12-18
Completion
2018-12-18
First posted
2017-10-31
Last updated
2020-09-30
Results posted
2020-08-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03326999. Inclusion in this directory is not an endorsement.